NFKB1 and cancer: This might be due to the absence of another GPX isoenzyme in monocytes, GPX2 [35], which has been previously shown to have overlapping functions with GPX1 in limiting the redox-dependent activation of the NF-κB pathway and LM biosynthesis in human epithelial-derived cancer cells [29].